An Open-label Long-term Safety Study of Buntanetap in Participants With AD

Clinical trial NCT07757204 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07757204
Sponsor: Annovis Bio Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer's Dementia (AD)

Start date: 2026-09-21
Primary completion: 2030-02-21
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.